2nd Inflammatory & Immunological Biomarkers

GTC is proud to present the 2nd Inflammatory & Immunological Biomarkers as part of our Biomarker Summit 2013, to be held on March 20-22, 2013 in San Francisco, California. This conference will discuss a wide range of issues in the biomarker field specific to inflammatory and immunological therapeutic areas. Topics such as novel approaches to biomarker discovery, enabling technologies, regulatory and reimbursement trends and the development of companion diagnostics will be discussed. Specific disease areas include cardiovascular disease, metabolic diseases, arthritis, autoimmune diseases, kidney / renal disease and inflammatory bowel disease. These areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector. Below is an agenda outline for this conference:

March 20th

Plenary Keynote Session

March 21st-22nd

Breakout: Inflammatory / Immunological Biomarkers

Inflammation and related Biomarkers in Cardiovascular Disease

Biomarkers of Inflammation in Kidney / Renal Disease

Inflammation in Metabolic Diseases

- Diabetes

- Obesity

Biomarkers of Autoimmune Diseases

- Rheumatoid arthritis

- SLE

Biomarkers of Inflammatory Bowel Disease

- Crohnes

- Ulsarative Colitis

Biomarkers in Respiratory Diseases

Molecular Pathways Linking Inflammation and Cancer

Mar 22nd

General Session

Regulatory & Reimbursement Updates in Biomarker Development

+ Panel Discussion

Companion Diagnostics Development & Partnering Strategies

+ Panel Discussion